These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 4884576

  • 1. Pharmacodynamic effects of a new antihypertensive drug, Catapres (ST-155).
    Onesti G, Schwartz AB, Kim KE, Swartz C, Brest AN.
    Circulation; 1969 Feb; 39(2):219-28. PubMed ID: 4884576
    [No Abstract] [Full Text] [Related]

  • 2. Mechanisms of antihypertensive drug therapy.
    Brest AN, Onesti G, Swartz C, Seller R, Kim E, Chinitz J.
    JAMA; 1970 Jan 19; 211(3):480-4. PubMed ID: 5466923
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of hypotensive substances (hypothiazide, guanetidine, alpha-methyldopa) on basic hemodynamic indices].
    Glezer GA.
    Kardiologiia; 1968 Aug 19; 8(8):113-8. PubMed ID: 5727457
    [No Abstract] [Full Text] [Related]

  • 4. [Comparative evaluation of the therapeutic effect and mechanism of action of isobarin and aldomet in hypertension].
    Erina EV, Zamyslova KN, Il'ina LI, Glezer GA, Pershakova LP, Vyshnepol'skiĭ IuIa, Labeeva TN.
    Kardiologiia; 1967 Mar 19; 7(3):35-41. PubMed ID: 4883577
    [No Abstract] [Full Text] [Related]

  • 5. Comparison between the effects of ST 600 and catapres.
    Kho TL, Schalekamp MA, Zaal GA, Wester A, Birkenhäger WH.
    Arch Int Pharmacodyn Ther; 1975 Apr 19; 214(2):347-50. PubMed ID: 1156039
    [Abstract] [Full Text] [Related]

  • 6. Comparison between the effects of ST 600 and clonidine.
    Kho TL, Schalekamp MA, Zaal GA, Wester A, Birkenhäger WH.
    Arch Int Pharmacodyn Ther; 1975 Sep 19; 217(1):162-9. PubMed ID: 1190909
    [Abstract] [Full Text] [Related]

  • 7. Treatment of severe hypertension with Catapres (St 155). A comparative study of the effect of catapres and methyldopa in a series of hypertensive outpatients (WHO stage 3).
    Becker-Christensen F, Bang HO, Ditzel J.
    Acta Med Scand; 1971 Sep 19; 190(1-2):21-6. PubMed ID: 5099124
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. HEMODYNAMIC EFFECTS OF PARGYLINE IN HYPERTENSIVE PATIENTS.
    ONESTI G, NOVACK P, RAMIREZ O, BREST AN, MOYER JH.
    Circulation; 1964 Dec 19; 30():830-5. PubMed ID: 14246326
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade.
    Gilmore E, Weil J, Chidsey C.
    N Engl J Med; 1970 Mar 05; 282(10):521-7. PubMed ID: 4391708
    [No Abstract] [Full Text] [Related]

  • 16. The effects of 2-(2,6-dichlorphenylamine)-2-imidazoline hydrochloride (Catapres) upon the systemic and coronary haemodynamics and metabolism of intact dogs.
    Maxwell GM.
    Arch Int Pharmacodyn Ther; 1969 Sep 05; 181(1):7-14. PubMed ID: 5350786
    [No Abstract] [Full Text] [Related]

  • 17. HEMODYNAMIC RESPONSE TO ANTIHYPERTENSIVE DRUG THERAPY.
    BREST AN.
    JAMA; 1965 Apr 05; 192():41-4. PubMed ID: 14262269
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of reserpine, guanethidine and methyldopa on cardiac output and its distribution.
    Kisin I, Yuzhakov S.
    Eur J Pharmacol; 1976 Feb 05; 35(2):253-60. PubMed ID: 1248504
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.